PTEN and non-small cell lung carcinoma: Furthermore, the enhancement effect of TP53TG1 on cisplatin sensitivity might be mediated by miR-18a/PTEN axis in NSCLC cell line, indicating a potential target for improving NSCLC chemotherapy.